NFKB1 and ovarian carcinoma: A recent study showed that β-Ele combined with paclitaxel inhibited growth and induced apoptosis of ovarian cancer cells, suggesting that β-Ele enhanced the anti-ovarian cancer effects of paclitaxel through regulation of the STAT3/NF-κB signaling pathway [28].